Xiwang Foodstuffs Vice Chairman Sun Xinguo: The scale of the rapeseed oil business is expanding, and the sports nutrition products are in a transitional stage. | Interview with Finance

1. With the decline in raw material prices such as corn and protein, xiwang foodstuffs' performance in the first three quarters showed high growth. The fourth quarter is the traditional peak season for corn oil, and it is expected that the earnings will further improve. 2. The company's sports nutrition business has started to grow steadily. In the first half of this year, xiwang foodstuffs' sports nutrition business revenue accounted for close to 50%, with a gross margin of 30.47%. The company plans to develop 2-3 major products in the next two years.

cls.cnNov 8 22:14

The pesticide market downturn dragged down aba chemicals corporation, which has been in continuous losses for five seasons, but the amount of losses has narrowed | interpretations

①Aba Chemicals Corporation has been experiencing losses for five consecutive quarters in Q3, but the amount of loss has narrowed compared to the first two quarters of this year; ②The pesticide industry is still at a low level, with a significant decrease in the market situation of the company's main product, chlorfenapyr acetylamine intermediate, within a year; ③The company's top ten shareholders underwent changes in Q3, with a new addition of an institutional shareholder and 'Northbound Funds'.

cls.cnOct 23 23:16

Hybio Pharmaceutical's H1 revenue continues to decline. Have active pharmaceutical ingredient orders become a "lifesaver"? | Interpretations

①In the first half of this year, hybio pharmaceutical's revenue decline trend has not stopped, and the net profit loss has narrowed to a certain extent; ②The formulation sector has been affected by block orders, with continuous revenue decline, and the active pharmaceutical ingredient sector has become the top revenue contributor; ③In the first half of this year, with efforts from multiple parties, hybio pharmaceutical has seen some relief in cash flow.

cls.cnAug 23 20:58

Is GLP-1, a concept stock, stuck in a money market quagmire due to the transfer of controlling shareholders' pledged loan shares worth 0.2 billion?

On the evening of the 15th, hybio pharmaceutical, a GLP-1 concept stock, announced that its controlling shareholder had transferred the pledged stocks worth more than 0.2 billion yuan to Shenzhen Guarantee. In the past year and the first quarter of this year, the controlling shareholder lent money to hybio pharmaceutical several times, while the financial reports for last year and Q1 of this year showed that hybio pharmaceutical's cash flow was relatively tight. The lawyer stated that the bottom line of the aforementioned stock pledge financing by the shareholder was in compliance and had no direct relation to hybio pharmaceutical's cash flow.

cls.cnJul 16 00:24

New developments in the case of former president's embezzlement, hybio pharmaceutical quickly made a statement! | Speed ​​reading announcement

Hybio Pharmaceutical announced the new development of the former CEO's suspected crime case, and the company immediately stated zero tolerance for illegal behavior. Prior to this, the case has gone through a first trial and sent back for retrial. The lawyer stated that when there are situations such as unclear or erroneous factual determinations and omissions of parties, the higher court will send the case back to the original court for retrial.

cls.cnJul 3 23:53

"1 yuan stock" dominates the top gainers list! Multiple companies are urgently rescuing themselves, is the dawn coming?

Recently, companies such as Wintime Energy, Zhongfu Straits, Dezhan Healthcare, Guangdong Meiyan Jixiang Hydropower, and Shenzhen Heungkong Holding have all announced buyback plans.

cls.cnJul 3 12:45